N- (1- (1-benzyl - 4-phenyl-1H-imidazol-2-YL) - 2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (KSP) inhibitors for the treatment of cancer

Details for Australian Patent Application No. 2005258135 (hide)

Owner Novartis Vaccines & Diagnostics, Inc.

Inventors Phillips, Megan; Duhl, David; Le, Vincent; Sharma, Anu; Mendenhall, Kris; Jazan, Elisa; Walter, Annette; Wang, Weibo; Brammeier, Nathan; Lagniton, Liana Marie; Bair, Kenneth Walter; Xi, Yi; Mieuli, Elizabeth; Martin, Eric; Yang, Hong; Boyce, Rustum S.; Sabramanian, Sharadha; Abrams, Tinya; Knapp, Mark; Pecchi, Sabina; Constantine, Ryan; Ramurthy, Savithri; Renhowe, Paul; Huh, Kay; Barsanti, Paul A.; Rama, Jain; Wayman, Kelly

Agent FB Rice

Pub. Number AU-B-2005258135

PCT Pub. Number WO2006/002236

Priority 60/580,927 18.06.04 US

Filing date 20 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 22 September 2011

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/002236 Priority application(s): WO2006/002236

8 January 2009 Alteration of Name

  The name of the applicant has been altered to Novartis Vaccines & Diagnostics, Inc.

22 September 2011 Application Accepted

  Published as AU-B-2005258135

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005258137-Validating client-receivers

2005258134-Bumper having separate energy absorber and fascia support